Tertius News is an AI-native newsroom: an AI model reads the linked source articles below and extracts what each outlet reported, so you can compare their coverage side by side. How this works →
Bengaluru 'Peptide Party' Cancelled After Regulator Inquiry
A planned 'peptide party' in Bengaluru was cancelled after the Karnataka Food Safety and Drug Administration sought details about the event from organisers. The invite-only biohacking event, scheduled for August 29, had drawn regulatory scrutiny and medical concern over the unsupervised use of peptides. The episode has highlighted the growing trend of DIY peptide use in India's wellness culture.
By Tertius News AI Desk3 distinct · 3 mastheads · 3 articlesVersion 2Coverage Published
Regulatory Scrutiny Halts Event
A planned 'peptide party' in Bengaluru was cancelled last week after Karnataka's food and drug regulator served a notice to the organisers, marking one of the first regulatory actions in India against the wellness trend. The event, scheduled for August 29 at a venue in the Koramangala neighbourhood, was promoted by Upsurge Labs LLP as an invite-only biohacking gathering where attendees could sample 'peptide tastings' alongside music, food, and networking.
The Karnataka Food Safety and Drug Administration (FSDA) issued a formal notice to the organisers seeking details on the identity, composition, source, regulatory classification, and intended use of the preparations. According to officials quoted by PTI, the FSDA said the publicity material appeared to indicate that 'peptide preparations/products may be promoted, displayed, supplied, distributed, recommended, administered or otherwise made available to participants'.
The medical community had raised red flags about the unsupervised distribution of medical compounds, warning of serious health risks including severe allergic reactions, hormonal imbalance, and organ strain. The FSDA demanded proof of the exact composition of the products, manufacturing sources, drug licences, evidence for health claims, and arrangements for medical supervision during the party.
Organisers said they intended only to educate participants about biohacking, not to cause harm, but could not immediately provide the comprehensive documentation required to meet human-use safety standards. They officially cancelled the meetup, saying there was no injectable or prescription material planned for the event (a claim that has not been independently verified).
The Rise of DIY Peptide Use
The cancelled Bengaluru event highlighted a growing trend in India's metros: the rise of DIY peptide therapies, where people seek out compounds themselves, decide what to take, and sometimes self-inject based on advice from social-media communities rather than doctors. The invite-only event had reportedly attracted more than 200 registrations for about 50 spots (a figure not independently verified).
Dr. Anoop Misra, a veteran internal medicine specialist, said the credibility of established peptide medicines does not automatically extend to every compound sold online under the same label. Dr. Santanu Tripathi, a senior pharmacologist who has served on scientific panels of the Central Drugs Standard Control Organisation (CDSCO), told India Today the trend was 'growing and alarming'. He said many DIY peptide preparations are 'developed, and to some extent purified in very crude matter' and may not be fit for human use. He also said he had heard of several such parties taking place, particularly in metro cities.
The appeal of these products is easy to understand, given the success of blockbuster diabetes and weight-loss drugs. However, as Dr. Misra pointed out, the fact that one peptide is a scientifically proven medicine does not mean another peptide is safe or effective.
What Are Peptides and What Are the Risks?
Peptides are short chains of amino acids, the basic building blocks of proteins. While proteins typically contain 50 or more amino acids, peptides are smaller, often containing anywhere from two to 50 amino acids. They act as biological signalling molecules, playing roles in hormone production, tissue repair, immune response, and metabolic regulation. The human body naturally produces many peptides, including insulin and endorphins, and synthetic versions are used in several approved medications.
However, the products circulating in the wellness and biohacking community raise serious safety concerns. Unregulated peptide products may contain different concentrations than stated on the label, may be contaminated, or may have deteriorated because of poor storage, Dr. Tripathi warned. Self-injection adds another layer of risk, including incorrect dosing, unsafe handling, improper dilution, and infections at the injection site. There is also the emerging concern of 'stacking', where users combine several peptides based on advice from online communities.
Dr. Jatin Kumar Majhi, associate consultant for endocrinology at Manipal Hospital in Bhubaneswar, told HT that patients may not always mention peptide use unless specifically asked, and weight loss and muscle building are common reasons for their interest. He added that obtaining a peptide through an informal seller may mean it has not been stored correctly, and with injectable products, sterility is another concern.
India's Regulatory Landscape
In its notice, the Karnataka FSDA cited the Drugs and Cosmetics Act, 1940, and said certain peptide preparations 'may fall within the regulatory framework applicable to drugs', depending on their composition, presentation, intended use, claims, and manner of administration.
India does not have an equivalent of the US compounding-pharmacy framework, so any legal supply route for peptides would likely need to go through the Central Drugs Standard Control Organisation (CDSCO), the country's drug regulator. This lack of a clear regulatory pathway for such products, combined with their growing popularity, presents an ongoing challenge for authorities and a potential public health concern, as highlighted by the recent events in Bengaluru.
How each outlet told it
A framing line is our reading of that outlet's own text — an interpretation, not a quotation and not a fact we assert. Check it against what the outlet published.
Framing: The headline highlights the cancellation of the Bengaluru 'peptide party' and connects it to the broader Silicon Valley trend, framing it as a news event with scientific context. — measured and informative, with a cautionary undertone regarding the wellness trend and unapproved peptides.
Facts Included:
Advertised as India's first, the Bengaluru 'Peptide Party' was called off last week after the Karnataka Food Safety and Drug Administration (FSDA) served a notice to the organisers.
The event was planned to be held in Koramangala on August 29 and was promoted by Upsurge Labs LLP.
The invite-only event promised 'peptide tastings', music, food and networking.
The FSDA, according to officials quoted by PTI, sought details on the identity, composition, source, regulatory classification and intended use of the preparations.
It said the publicity material appeared to indicate that 'peptide preparations/products may be promoted, displayed, supplied, distributed, recommended, administered or otherwise made available to participants'.
The event was eventually cancelled, and its organisers later said there was no injectable or prescription material planned for the event.
Local news website San Francisco Standard reported in August that 'sexmaxxing', inspired from the concept of 'looksmaxxing', was an emerging trend that involved injecting peptides before dates.
Peptides are short chains of amino acids that act as signalling molecules in the body.
Approved peptide drugs include insulin, GLP-1 drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, and bremelanotide(Vyleesi).
A 2015 study published in the American Chemical Society journal Molecular Pharmaceutics by researchers at University College London's School of Pharmacy tested 17 peptide drugs in human gastric and intestinal fluids, and found that small and large peptides degraded rapidly.
Only cyclic peptides such as ciclosporin and disulfide-bridged peptides such as octreotideand desmopressin survived.
A 2024 clinical review in the National Library of Medicine's PubMed Central archive reported that typical oral bioavailability(the proportion of a drug that reaches the bloodstream in active form) for peptide drugs is below 1%, and sometimes below
1%.
Oral semaglutide (Rybelsus), the only widely marketed oral peptide drug, achieves about 1% bioavailability,and only because it is extremely potent and paired with a specialised absorption enhancer.
Injection avoids the absorption problem, which is why most approved peptide drugs such as insulin and the GLP-1s go through the needle.
A 2025 review in the journal Pharmaceuticals found that BPC-157, a popular compound among biohackers, has been studied extensivelyin animal models but has not been through large, controlled human trials.
Rachel Pessah-Pollack, an endocrinologistat NYU Langone Health, told CBS News that BPC-157 had been tested in only about 30 humans, compared with hundreds of thousands for GLP-1 drugs.
Anecdotes, she warned,'are not evidence'.
Bryan Johnson, the American entrepreneur who sold his mobile payments firm Braintree to PayPal in 2013 for $800 million, has been the most public face of the movement.
His 'Blueprint' for longevity has become a template for other enthusiasts and his documented regimen includes peptides in supplement and injectable forms.
Dave Asprey, founder of Bulletproof Coffee, has openly discussed his peptide and stem-cell use.
Andrew Huberman, an associate professor at Stanford University School of Medicine and a scientist often criticised by his peers, also discussed the peptide PT-141 on his podcast in 2024 and 2025.
PT-141, whose approved brand name is Vyleesi, was cleared by the US Food and Drug Administration(FDA)in 2019, but only for hypoactive sexual desire disorder in premenopausal women.
Its sale as an all-purpose'arousal peptide' through Johnson's platform is therefore off-label,and dispensed on prescriptions written by'd octors' available on the platform.
Among the many backers is billionaire Silicon Valley investor and PayPal co-founder Peter Thiel as well.
An article in the Journal of the American Medical Association(JAMA)said that peptide-related content had crossed 130,000 posts on Instagram and 230 million views on TikTok by May 2026.
The authors said the market was a ' grey zone' that spanned medicine, wellness and illicit drug markets,' making them difficult to classify, regulate and monitor within existing frameworks'.
In the US, the FDA is being prodded to loosen rules on several unapproved peptides.
Earlier this year, a panel recommended allowing the use of BPC-157 and some other peptides by compounding pharmacies.
India does not have an equivalent of the US compounding-pharmacy framework, so any legal supply route for peptides would likely need to go through the Central Drugs Standard Control Organisation(CDSCO,the country's drug regulator.
In its notice, the Karnataka FSDA citedthe Drugs and Cosmetics Act,1940,and said certain peptide preparations, depending on their composition,presentation,intended use,claims and manner of administration,'may fall within the regulatory framework applicable to'drugs''.
Dr Jatin Kumar Majhi, associate consultant for endocrinologyat Manipal Hospital in Bhubaneswar, told HTthat patients may not always mention peptide use unless specifically asked, and weight loss and muscle building are common reasons for their interest.
Dr Majhi also said that obtaining a peptide through an informal seller may mean it has not been stored correctly, and that with injectable products, sterility is another concern.
Framing: The headline emphasizes the cancellation of a Bengaluru peptide party as an exposure of a risky DIY wellness trend in India.
Facts Included:
A planned 'Peptide Party' in Bengaluru was cancelled after the Karnataka Food Safety and Drug Administration sought details from the organisers about the preparations, including their composition, manufacturers, regulatory status, dosage and intended use.
The invite-only event had reportedly attracted more than 200 registrations for about 50 spots.
Dr Anoop Misra, a veteran internal medicine specialist, said the credibility of established peptide medicines does not automatically extend to every compound sold online under the same label.
Peptides are short chains of amino acids, the same basic building blocks that make up proteins.
Insulin is a peptide hormone used to control blood glucose in people with diabetes.
Semaglutide, used in medicines such as Ozempic and Wegovy, mimics the action of the naturally occurring hormone GLP-1.
Tirzepatide, the active ingredient in Monjaro, belonging to the same class of formulation, has also demonstrated substantial benefits for diabetes and weight management.
Teriparatide, a synthetic form of part of the parathyroid hormone, is used to treat osteoporosis and reduce fracture risk in appropriate patients.
Several forms of glucagon are used to treat severe hypoglycaemia.
BPC-157, TB-500, epitalon and MOTS-c are among the names circulating in these communities.
In July this year, the US Food and Drug Administration (FDA) recommended against adding BPC-157 to its list of substances eligible for certain forms of compounding, citing inadequate evidence of safety and effectiveness.
Dr Santanu Tripathi, a senior pharmacologist who has served on scientific panels of the Central Drugs Standard Control Organisation (CDSCO), told India Today, the trend was 'growing and alarming.'
Dr Tripathi said many DIY peptide preparations are 'developed, and to some extent purified in very crude matter' and may not be fit for human use.
Dr Tripathi also said he had heard of several such parties taking place, particularly in metro cities.
The biggest danger is that consumers may not know precisely what they are injecting or swallowing.
Unregulated products may contain a different concentration from what is stated on the label, may be contaminated or may have deteriorated because of poor storage.
Testing of some peptides obtained online has also raised concerns about contamination and discrepancies between labelled and actual quantities.
Self-injection adds another layer of risk: incorrect dosing, unsafe handling, improper dilution and infections at the injection site.
There is another emerging concern:'stacking', where users combine several peptides based on advice from online communities.
Framing: Headline frames the event as a mystery to be explained: why the party was banned, with an 'Explained' tag indicating explanatory journalism
Facts Included:
The 'peptide party' scheduled for August 29 in Koramangala in Bengaluru was cancelled after Karnataka Food Safety and Drug Administration officials shut down the gig
It was an invite-only biohacking event that was advertised only online, offering — among other party staples like music and networking — 'peptide tasting'
The event was called off after doctors raised red flags about the unsupervised distribution of medical compounds, saying this would pose serious risks to health, including severe “allergic reactions, hormonal imbalance, and organ strain.”
The Karnataka Food Safety and Drug Administration team stepped in, issuing a formal notice to the organisers, demanding proof of the exact composition of the products, manufacturing sources, Drug licenses, evidence for health claims, and the proposed arrangements for medical supervision during the party
The organisers said they intended only to educate participants about biohacking, not to cause harm, but they couldn’t immediately provide the comprehensive documentation required to meet human-use safety standards
They officially cancelled the meetup
Peptides are the fundamental building blocks of proteins, shorter chains of amino acids
Proteins, on the other hand, are typically long, complex chains of 50 or more amino acids
Peptides are smaller, often containing anywhere from two to 50 amino acids
They serve as biological signalling molecules and instruct cells, including being the starting point for functions including hormone production, tissue repair, immune response and metabolic regulation
The key point is that the human body naturally produces many peptides; common ones in the public domain include insulinand endorphins
Synthetic proteins have also been created in laboratories for therapeutic uses — even these are quite common — synthetic insulinand more recently, GLP-1 receptor agonists popular as weight-loss drugs
Biohackers use specific synthetic or medical peptides to mimic natural hormones, boost muscle development, or speed up healing
In a paper in Cureus in June this year, Kirubel T. Hailu et al discuss Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks
Media reports say that the planned peptide party in Bengaluru was to be an intimate gathering (around 50 attendees, bringing together people from all walks of life interested in ‘biohacking’
Promotional material circulated online hyping up the meet to be the start of the ‘next wave of science’, offering testing samples of peptides
They also warned that misdosing or overdosing can lead to severe complications for individuals
AI-extracted; can misattribute a claim — see Methodology.
Each row is one claim, attributed to the outlet whose wording states it most clearly. Confidence rates how directly the source text states the claim — explicit and unhedged rates high; hedged, pieced-together, or internally inconsistent statements rate lower. It does not measure whether the claim is true. Status is Contested when two claims on this page negate each other; otherwise it counts the distinct outlets we found asserting that specific claim — so a single-source claim can still show high confidence, and a multi-source claim can show medium. Every one of those outlets is named beside the status, so you can check the count against the list. For claims extracted before we began storing that list, the row says so: it names the outlet the claim is quoted from and states that we have not recorded which outlets backed it. Outlets wrote at different times, so a figure that evolves — a casualty count, for example — can legitimately differ between rows; check the "as of" time next to each claim's source.
Claim
Confidence
Status
ClaimThe Bengaluru 'Peptide Party' scheduled for August 29 in Koramangala was cancelled after the Karnataka Food Safety and Drug Administration served a notice to the organisers.
ClaimThe Karnataka FSDA issued a formal notice to the organisers demanding details on the identity, composition, source, regulatory classification and intended use of the preparations.
ClaimThe FSDA's notice stated that the publicity material appeared to indicate that peptide preparations/products may be promoted, displayed, supplied, distributed, recommended, administered or otherwise made available to participants.
ClaimThe event was cancelled after doctors raised red flags about the unsupervised distribution of medical compounds, citing risks including allergic reactions, hormonal imbalance, and organ strain.
ClaimThe organisers said they intended only to educate participants about biohacking, not to cause harm, but they could not immediately provide the comprehensive documentation required to meet human-use safety standards, so they officially cancelled the meetup.
ClaimProteins are typically long, complex chains of 50 or more amino acids, whereas peptides are smaller, often containing anywhere from two to 50 amino acids.
ClaimSynthetic proteins and peptides have been created in laboratories for therapeutic uses, including synthetic insulin and GLP-1 receptor agonists as weight-loss drugs.
ClaimSemaglutide, used in medicines such as Ozempic and Wegovy, mimics the action of the naturally occurring hormone GLP-1 and helps regulate blood sugar and reduce appetite.
ClaimA 2015 study published in Molecular Pharmaceutics by researchers at University College London's School of Pharmacy tested 17 peptide drugs in human gastric and intestinal fluids and found that small and large peptides degraded rapidly.
ClaimOnly cyclic peptides such as ciclosporin and disulfide-bridged peptides such as octreotide and desmopressin survived degradation in human gastric and intestinal fluids.
ClaimOral semaglutide (Rybelsus), the only widely marketed oral peptide drug, achieves about 1% bioavailability,and only because it is extremely potent and paired with a specialised absorption enhancer.
ClaimA 2025 review in the journal Pharmaceuticals found that BPC-157 has been studied extensivelyin animal models but has not been through large, controlled human trials.
ClaimRachel Pessah-Pollack, an endocrinologistat NYU Langone Health, told CBS News that BPC-157 had been tested in only about 30 humans, compared with hundreds of thousands for GLP-1 drugs.
ClaimBryan Johnson, who sold Braintree to PayPal in 2013 for $800 million, has been a prominent figure in the longevity movement and his 'Blueprint' regimen includes peptides.
ClaimPT-141, whose approved brand name is Vyleesi, was cleared by the US Food and Drug Administration in 2019 for hypoactive sexual desire disorder in premenopausal women.
ClaimThe sale of PT-141 through Johnson's platform as an all-purpose 'arousal peptide' is off-label,and it is dispensed on prescriptions written by doctors available on the platform.
ClaimAn article in the Journal of the American Medical Association said that peptide-related content had crossed 130,000 posts on Instagram and 230 million views on TikTok by May 2026.
ClaimThe JAMA authors called the peptide market a 'grey zone' spanning medicine, wellness and illicit drug markets, making it difficult to classify, regulate and monitor.
ClaimIn July this year, the US FDA recommended against adding BPC-157 to its list of substances eligible for certain forms of compounding, citing inadequate evidence of safety and effectiveness.
ClaimIndia does not have an equivalent of the US compounding-pharmacy framework, so any legal supply route for peptides would likely need to go through the Central Drugs Standard Control Organisation (CDSCO).
ClaimIn its notice,the Karnataka FSDA cited the Drugs and Cosmetics Act,1940,and said certain peptide preparations may fall within the regulatory framework applicable to'drugs'.
ClaimDr Jatin Kumar Majhi, an endocrinologist at Manipal Hospital in Bhubaneswar, told HT that patients may not always mention peptide use unless specifically asked,and weight loss and muscle building are common reasons for their interest.
ClaimDr Majhi said that obtaining a peptide through an informal seller may mean it has not been stored correctly,and that with injectable products, sterility is another concern.
ClaimThe Frontiers in Aging review flagged the concern that peptides that stimulate growth hormone or are marketed for anti-ageing could help existing cancer cells grow faster,and advised against their use in patients with pre-existing cancers.
ClaimPromotional material for the Bengaluru peptide party circulated online hyped the meet as the start of the 'next wave of science', offering testing samples of peptides.
ClaimThe Karnataka FSDA demanded proof of the exact composition of the products, manufacturing sources, Drug licenses, evidence for health claims,and arrangements for medical supervision during the party.
ClaimDr Anoop Misra, a veteran internal medicine specialist, said the credibility of established peptide medicines does not automatically extend to every compound sold online under the same label.
ClaimUnregulated peptide products may contain a different concentration from what is stated on the label, may be contaminated or may have deteriorated because of poor storage.